Centenial Surgical Suture Intrinsic Value
Centenial Surgical Suture (CSURGSU) median intrinsic value is ₹188.00 from 4 valuation models (range ₹120–₹235), vs current price ₹94.00 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. Also explore CSURGSU share price charts to track price trends across different timeframes.
CSURGSU Valuation Methods Summary — DCF, Graham Number & P/E
Centenial Surgical Suture intrinsic value across 4 models vs current price ₹94.00 — upside/downside and value range per method. For current market price and key ratios, visit Centenial Surgical Suture stock price NSE.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹124.00 | ₹111.60 - ₹136.40 | +31.9% | Book Value/Share: ₹62.00, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹188.00 | ₹169.20 - ₹206.80 | +100.0% | Revenue/Share: ₹110.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹120.00 | ₹108.00 - ₹132.00 | +27.7% | EBITDA: ₹6.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹235.00 | ₹188.00 - ₹282.00 | +150.0% | CF Growth: 15.0%, Discount: 15% |
CSURGSU Intrinsic Value vs Market Price — All Valuation Models
Centenial Surgical Suture fair value range ₹120–₹235 vs current market price ₹94.00 across 4 valuation models. Browse CSURGSU annual financials for revenue, profit, balance sheet and cash flow data.
CSURGSU Intrinsic Value Analysis — Undervalued or Overvalued?
Centenial Surgical Suture median intrinsic value ₹188.00, current price ₹94.00 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of CSURGSU?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Centenial Surgical Suture (CSURGSU) is ₹188.00 (median value). With the current market price of ₹94.00, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹120.00 to ₹235.00, indicating ₹120.00 - ₹235.00.
Is CSURGSU undervalued or overvalued?
Based on our multi-method analysis, Centenial Surgical Suture (CSURGSU) appears to be trading below calculated value by approximately 100.0%.
CSURGSU Financial Health — Key Ratios vs Industry Benchmarks
Centenial Surgical Suture financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 2.86 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -3.2% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 11.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.65x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
CSURGSU Cash Flow Quality — Operating & Free Cash Flow
Centenial Surgical Suture operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹17 Cr | ₹11 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹6 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹5 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |